After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, INO falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.75 and fluctuated between $0.8150 as its day high and $0.6968 as its day low. The current market capitalization of Inovio Pharmaceuticals Inc is $205.12M. A total of 5.54 million shares were traded on the day, compared to an average of 3.55M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, INO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 22 BUYs and 13 SELLs from insiders. Insiders purchased 692,311 shares during that period but sold 241,286.
In the most recent transaction, Zoth Lota S. sold 5,700 shares of INO for 0.56 per share on Jun 05. After the transaction, the Director now owns 52,716 company shares. In a previous transaction on Mar 13, Weiner David B. sold 5,833 shares at 1.15 per share. INO shares that Director owns now total 910,124.
Among the insiders who sold shares, Weiner David B. disposed of 11,668 shares on Feb 27 at a per-share price of $1.28. This resulted in the Director holding 904,291 shares of INO after the transaction.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for INO in the last 3 months, the mean price target is $0.70 with high estimates of $1.00 and low estimates of $0.40. In terms of 52-week highs and lows, INO has a high of $1.99 and a low of $0.32.
As of this writing, INO has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.15. The company reported an EPS of -$0.13 in the last quarter, which was 7.10% higher than expectations of -$0.14.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. INO’s latest balance sheet shows that the firm has $401.31M in Cash & Short Term Investments as of fiscal 2021. There were $33.02M in debt and $65.74M in liabilities at the time. Its Book Value Per Share was $0.51, while its Total Shareholder’s Equity was $399.67M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INO is Buy with a score of 3.40.
